Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jan;130(1):e148-e159.
doi: 10.1016/j.bja.2022.04.023. Epub 2022 Jun 9.

Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study

Douglas A Colquhoun  1 , Michelle T Vaughn  2 , Lori D Bash  3 , Allison Janda  2 , Nirav Shah  2 , Amir Ghaferi  4 , Michael Sjoding  5 , Graciela Mentz  2 , Sachin Kheterpal  2 ; Multicenter Perioperative Outcomes Group (MPOG) Perioperative Clinical Research Committee
Collaborators, Affiliations
Multicenter Study

Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study

Douglas A Colquhoun et al. Br J Anaesth. 2023 Jan.

Abstract

Background: Postoperative pulmonary complications are a source of morbidity after major surgery. In patients at increased risk of postoperative pulmonary complications we sought to assess the association between neuromuscular blocking agent reversal agent and development of postoperative pulmonary complications.

Methods: We conducted a retrospective matched cohort study, a secondary analysis of data collected in the prior STRONGER study. Data were obtained from the Multicenter Perioperative Outcomes Group. Included patients were aged 18 yr and older undergoing non-emergency surgery under general anaesthesia with tracheal intubation with neuromuscular block and reversal, who were predicted to be at elevated risk of postoperative pulmonary complications. This risk was defined as American Society of Anesthesiologists Physical Status 3 or 4 in patients undergoing either intrathoracic or intra-abdominal surgery who were either aged >80 yr or underwent a procedure lasting >2 h. Cohorts were defined by reversal with neostigmine or sugammadex. The primary composite outcome was the occurrence of pneumonia or respiratory failure.

Results: After matching by institution, sex, age (within 5 yr), body mass index, anatomic region of surgery, comorbidities, and neuromuscular blocking agent, 3817 matched pairs remained. The primary postoperative pulmonary complications outcome occurred in 224 neostigmine cases vs 100 sugammadex cases (5.9% vs 2.6%, odds ratio 0.41, P<0.01). After adjustment for unbalanced covariates, the adjusted odds ratio for the association between sugammadex use and the primary outcome was 0.39 (P<0.0001).

Conclusions: In a cohort of patients at increased risk for pulmonary complications compared with neostigmine, use of sugammadex was independently associated with reduced risk of subsequent development of pneumonia or respiratory failure.

Keywords: neostigmine; neuromuscular blocking drug; pneumonia; postoperative pulmonary complications; respiratory failure; reversal of neuromuscular block; sugammadex.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Study flow chart describing study population, exclusion criteria, and relationship of this population with the prior STRONGER study. NMB, neuromuscular blocking agent; OR, operating room; ICU, Intensive Care Unit.
Fig 2
Fig 2
Adjusted odds ratio (with confidence intervals) for primary and secondary outcomes.
See this image and copyright information in PMC

Comment in

References

    1. Fernandez-Bustamante A., Frendl G., Sprung J., et al. Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators. JAMA Surg. 2017;152:157–166. - PMC - PubMed
    1. Vegas investigators L.A.S. Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS – an observational study in 29 countries. Eur J Anaesthesiol. 2017;34:492–507. - PMC - PubMed
    1. Fleisher L.A., Linde-Zwirble W.T. Incidence, outcome, and attributable resource use associated with pulmonary and cardiac complications after major small and large bowel procedures. Perioper Med (Lond) 2014;3:7. - PMC - PubMed
    1. Khuri S.F., Henderson W.G., DePalma R.G., et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326–341. ; discussion 341–3. - PMC - PubMed
    1. Neto A.S., da Costa L.G.V., Hemmes S.N.T., et al. The LAS VEGAS risk score for prediction of postoperative pulmonary complications: an observational study. Eur J Anaesthesiol. 2018;35:691–701. - PMC - PubMed

Publication types

MeSH terms